Cas:6476-37-5 Dicyclohexylphenylphosphine manufacturer & supplier

Chemical Name:Dicyclohexylphenylphosphine

CAS.NO:6476-37-5

Synonyms:EINECS 229-334-7;dicyclohexyl(phenyl)phosphane;MFCD00003854

Molecular Formula:C₁₈H₂₇P

Molecular Weight:274.38100

HS Code:2902909090

Physical and Chemical Properties:

Melting point:60-61 °C(lit.)

Boiling point:391.8ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:13.59000

Exact Mass:274.18500

LogP:5.45920

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like EINECS 229-334-7 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00003854 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,dicyclohexyl(phenyl)phosphane Use and application,MFCD00003854 technical grade,usp/ep/jp grade.

Related News: Last year, California became the first state in the country to ban toxic chemicals in cosmetics — including a number of PFAS. Maryland did the same this month, but the laws don’t take effect until 2025, the Post reported. Dicyclohexylphenylphosphine manufacturer In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. Dicyclohexylphenylphosphine supplier In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase. Dicyclohexylphenylphosphine vendor Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs. Dicyclohexylphenylphosphine factory Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.